Close

Allos Therapeutics (ALTH) Posts Q2 Loss of $0.19, Narrower than Views

July 28, 2010 8:22 AM EDT Send to a Friend
Allos Therapeutics (Nasdaq: ALTH) reports Q2 loss ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login